After FDA EMA also likely to approve Fintepla... Oct 19
Zogenix receives positive CHMP opinion for FINTEPLA (Fenfluramine) oral solution for the treatment of seizures in patients with dravet syndrome ... Oct 17
Commercial launch planned for July 2020... Jun 26
-Advertisements-